ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lilly Reports LARTRUVO Study Did Not Meet Primary Endpoint americanpharmaceuticalreview
January 23, 2019Eli Lilly and Company reported the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combination with doxorubicin in patients with advanced or metastatic soft tissue sarcoma (STS)....
Pharma Sources Insight July 2025
